AMYLOIDOSIS
Clinical trials for AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to tackle rare amyloid disease
Disease control Not yet recruitingThis study tests a new drug, belantamab mafodotin, added to standard chemotherapy for adults newly diagnosed with AL amyloidosis, a rare disease where abnormal proteins build up in organs. About 60 participants will receive different doses to find the best balance of effectivenes…
Matched conditions: AMYLOIDOSIS
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 26, 2026 03:58 UTC
-
Heart help: 5-Week rehab program tested for rare heart condition
Symptom relief Not yet recruitingThis study looks at whether a 5-week cardiac rehabilitation program can improve exercise ability and quality of life in 40 adults with cardiac amyloidosis. Participants will complete the program and have tests before and after to measure heart and lung function, symptoms, and wel…
Matched conditions: AMYLOIDOSIS
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC